Hypo-immunogenic cardiac patches for myocardial regeneration
Grant Award Details
Grant Type:
Grant Number:
DISC1-09984
Investigator(s):
Disease Focus:
Human Stem Cell Use:
Award Value:
$235,818
Status:
Closed
Progress Reports
Reporting Period:
Year 1
Grant Application Details
Application Title:
Hypo-immunogenic cardiac patches for myocardial regeneration
Public Abstract:
Research Objective
To engineer a cardiac patch to restore function after a heart attack while avoiding an immune response (“hypo-immunogeneic” CP) when transplanted into a genetically distinct (“allogenic”) individual.
Impact
By making hypo-immunogeneic CPs and functional cardiac cells (induced pluripotent stem, “iPS” cells) available to commercial/research entities, our study can fuel the transformation of healthcare.
Major Proposed Activities
To engineer a cardiac patch to restore function after a heart attack while avoiding an immune response (“hypo-immunogeneic” CP) when transplanted into a genetically distinct (“allogenic”) individual.
Impact
By making hypo-immunogeneic CPs and functional cardiac cells (induced pluripotent stem, “iPS” cells) available to commercial/research entities, our study can fuel the transformation of healthcare.
Major Proposed Activities
- To generate human cardiac patches using human hypo-immunogeneic iPS cell-derived cardiomyocytes and endothelial cells and perform optical mapping of the epicardial surface after transplantation.
- To study the survival of hypo-immunogeneic cardiac patches after myocardial infarction as well as their immunological acceptance and integration.
Statement of Benefit to California:
Cardiac patches with hypo-immunogeneic iPS cells have potential to restore function and prevent immune rejection, eliminating costly complications of systemic immunosuppression after pluripotent stem cell transplantation. Besides its enormous potential to improve the health of California residents, our breakthrough would also inevitably lead to licensing opportunities as well as FDA-approved cell regeneration therapy, which would generate significant future revenues for the State of California.
